Business Description
Quest PharmaTech Inc
NAICS : 325412
SIC : 3741
ISIN : CA74836M1068
Compare
Compare
Traded in other countries / regions
QPT.CanadaQPTFF.USA IPO Date
1999-03-30Description
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.76 | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 48.9 | |||||
3-Year Book Growth Rate | -49.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.41 | |||||
9-Day RSI | 39.98 | |||||
14-Day RSI | 41.02 | |||||
12-1 Month Momentum % | -64.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.54 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -1.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | 2.5 | |||||
ROA % | 2.45 | |||||
ROIC % | -2.32 | |||||
ROC (Joel Greenblatt) % | 1778.38 | |||||
ROCE % | 2.55 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2.14 | |||||
PE Ratio without NRI | 1 | |||||
Shiller PE Ratio | 1.06 | |||||
Price-to-Owner-Earnings | 2.14 | |||||
PB Ratio | 0.11 | |||||
Price-to-Tangible-Book | 0.12 | |||||
EV-to-EBIT | 2.3 | |||||
EV-to-EBITDA | 2.3 | |||||
EV-to-FCF | -6.46 | |||||
Price-to-Graham-Number | 0.07 | |||||
Earnings Yield (Greenblatt) % | 43.48 | |||||
FCF Yield % | -18.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quest PharmaTech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | 0.007 | ||
Beta | -0.79 | ||
Volatility % | 78.71 | ||
14-Day RSI | 41.02 | ||
14-Day ATR (C$) | 0.003922 | ||
20-Day SMA (C$) | 0.023 | ||
12-1 Month Momentum % | -64.29 | ||
52-Week Range (C$) | 0.015 - 0.07 | ||
Shares Outstanding (Mil) | 169.13 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quest PharmaTech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quest PharmaTech Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Quest PharmaTech Inc Frequently Asked Questions
What is Quest PharmaTech Inc(TSXV:QPT)'s stock price today?
The current price of TSXV:QPT is C$0.02. The 52 week high of TSXV:QPT is C$0.07 and 52 week low is C$0.02.
When is next earnings date of Quest PharmaTech Inc(TSXV:QPT)?
The next earnings date of Quest PharmaTech Inc(TSXV:QPT) is .
Does Quest PharmaTech Inc(TSXV:QPT) pay dividends? If so, how much?
Quest PharmaTech Inc(TSXV:QPT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |